Synopsys, Inc. (SNPS) Reports In-Line Q4 EPS; Guides Q1, FY12 EPS, Revs
Tweet
Share
E-mailGet Alerts SNPS Hot Sheet
Price: $455.51 -1.35%
Revenue Growth %: +40.2%
Financial Fact:
Amortization of intangible assets: 22.57M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +40.2%
Financial Fact:
Amortization of intangible assets: 22.57M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Synopsys, Inc. (NASDAQ: SNPS) reported Q4 EPS of $0.45, in-line with the analyst estimate of $0.45. Revenue for the quarter came in at $390.5 million versus the consensus estimate of $390.11 million.
Synopsys, Inc. sees Q1 2012 EPS of $0.51-$0.53, versus the consensus of $0.46. Synopsys, Inc. sees Q1 2012 revenue of $412-$420 million, versus the consensus of $389.0 million.
Synopsys, Inc. sees FY2012 EPS of $1.93-$1.99, versus the consensus of $1.96. Synopsys, Inc. sees FY2012 revenue of $1.64-$1.665 billion, versus the consensus of $1.65 billion.
Synopsys, Inc. sees Q1 2012 EPS of $0.51-$0.53, versus the consensus of $0.46. Synopsys, Inc. sees Q1 2012 revenue of $412-$420 million, versus the consensus of $389.0 million.
Synopsys, Inc. sees FY2012 EPS of $1.93-$1.99, versus the consensus of $1.96. Synopsys, Inc. sees FY2012 revenue of $1.64-$1.665 billion, versus the consensus of $1.65 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Sonoma Pharmaceuticals (SNOA) Misses Q4 EPS by 33c
- John Wiley & Sons, Inc. (WLYB) Tops Q4 EPS by 12c; Offers Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
